us-abfm MCQ (SBA): Obesity Pharmacotherapy in T2DM

Instant feedback + full explanation. One question, done properly.

EasyEndocrinologyObesity Pharmacotherapy in T2DMus-abfmus-abimus-usmle-step-2

A 52-year-old man with T2DM and obesity is interested in weight loss therapy. Which medication class has substantial weight loss and CV benefits?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

us-abfm MCQ: Obesity Pharmacotherapy in T2DM — Answer & Explanation |